Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
$1.4M Buy
12,150
+52
+0.4% +$5.61K 0.37% 72
2022
Q4
$1.34M Buy
12,098
+1,002
+9% +$102K 0.37% 70
2022
Q3
$1.03M Sell
11,096
-1,504
-12% -$134K 0.29% 87
2022
Q2
$1.17M Buy
12,600
+3,580
+40% +$317K 0.31% 71
2022
Q1
$781K Sell
9,020
-1,925
-18% -$152K 0.19% 110
2021
Q4
$894K Buy
10,945
+2,115
+24% +$168K 0.19% 115
2021
Q3
$712K Sell
8,830
-2,715
-24% -$206K 0.16% 135
2021
Q2
$902K Sell
11,545
-3,326
-22% -$247K 0.2% 123
2021
Q1
$1.11M Buy
+14,871
New +$1.1M 0.27% 99

Other funds holding MRK

Stonnington Group's MRK Position: Q1 2023 in Review

Stonnington Group increased its Merck (MRK) stake by 0.43% in Q1 2023, buying an estimated $5.61K and bringing the position to 12,150 shares worth $1.4M. The position accounts for 0.37% of the portfolio, ranked #72.

Stonnington Group first reported a position in MRK in Q1 2021 and has held it in 9 quarters since. 3,179 funds tracked by Wall St. Rank hold MRK as of Q1 2023.

  • Stonnington Group held 12,150 shares of Merck worth $1.4M as of Q1 2023.
  • Stonnington Group bought 52 Merck shares in Q1 2023, an estimated $5.61K.
  • Merck made up 0.37% of Stonnington Group's portfolio in Q1 2023, its #72 holding.
  • Stonnington Group first reported a position in Merck in Q1 2021 and has held it in 9 quarters since.
  • 3,179 funds tracked by Wall St. Rank held Merck as of Q1 2023.

Based on Stonnington Group's 13F filing for Q1 2023, filed 14 Apr 2023.